These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34122407)

  • 21. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
    Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
    Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
    Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
    Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naïve Human Macrophages Are Refractory to SARS-CoV-2 Infection and Exhibit a Modest Inflammatory Response Early in Infection.
    Zhang Z; Penn R; Barclay WS; Giotis ES
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus infection: An immunologists' perspective.
    De Sanctis JB; García AH; Moreno D; Hajduch M
    Scand J Immunol; 2021 Jun; 93(6):e13043. PubMed ID: 33783027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
    Zhang J; Wu H; Yao X; Zhang D; Zhou Y; Fu B; Wang W; Li H; Wang Z; Hu Z; Ren Y; Sun R; Tian Z; Bian X; Wei H
    Cell Mol Immunol; 2021 May; 18(5):1305-1307. PubMed ID: 33742186
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
    Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
    PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.
    Thorne LG; Reuschl AK; Zuliani-Alvarez L; Whelan MVX; Turner J; Noursadeghi M; Jolly C; Towers GJ
    EMBO J; 2021 Aug; 40(15):e107826. PubMed ID: 34101213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
    Bergamaschi L; Mescia F; Turner L; Hanson AL; Kotagiri P; Dunmore BJ; Ruffieux H; De Sa A; Huhn O; Morgan MD; Gerber PP; Wills MR; Baker S; Calero-Nieto FJ; Doffinger R; Dougan G; Elmer A; Goodfellow IG; Gupta RK; Hosmillo M; Hunter K; Kingston N; Lehner PJ; Matheson NJ; Nicholson JK; Petrunkina AM; Richardson S; Saunders C; Thaventhiran JED; Toonen EJM; Weekes MP; ; Göttgens B; Toshner M; Hess C; Bradley JR; Lyons PA; Smith KGC
    Immunity; 2021 Jun; 54(6):1257-1275.e8. PubMed ID: 34051148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
    Ricci D; Etna MP; Severa M; Fiore S; Rizzo F; Iannetta M; Andreoni M; Balducci S; Stefanelli P; Palamara AT; Coccia EM
    Int Immunopharmacol; 2023 Apr; 117():109996. PubMed ID: 36933449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.
    Munnur D; Teo Q; Eggermont D; Lee HHY; Thery F; Ho J; van Leur SW; Ng WWS; Siu LYL; Beling A; Ploegh H; Pinto-Fernandez A; Damianou A; Kessler B; Impens F; Mok CKP; Sanyal S
    Nat Immunol; 2021 Nov; 22(11):1416-1427. PubMed ID: 34663977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 evades immune detection in alveolar macrophages.
    Dalskov L; Møhlenberg M; Thyrsted J; Blay-Cadanet J; Poulsen ET; Folkersen BH; Skaarup SH; Olagnier D; Reinert L; Enghild JJ; Hoffmann HJ; Holm CK; Hartmann R
    EMBO Rep; 2020 Dec; 21(12):e51252. PubMed ID: 33112036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Toll-like receptors in the pathogenesis of COVID-19.
    Khanmohammadi S; Rezaei N
    J Med Virol; 2021 May; 93(5):2735-2739. PubMed ID: 33506952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasomes and SARS-CoV-2 Infection.
    Kaivola J; Nyman TA; Matikainen S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects.
    Jarmoluk P; Sviercz FA; Cevallos C; Freiberger RN; López CA; Poli G; Delpino MV; Quarleri J
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological Biomarkers of COVID-19.
    Lei R; Mohan C
    Crit Rev Immunol; 2020; 40(6):497-512. PubMed ID: 33900694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19.
    Laurent P; Yang C; Rendeiro AF; Nilsson-Payant BE; Carrau L; Chandar V; Bram Y; tenOever BR; Elemento O; Ivashkiv LB; Schwartz RE; Barrat FJ
    Sci Immunol; 2022 Sep; 7(75):eadd4906. PubMed ID: 36083891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.